Literature DB >> 27200967

Significant and Meaningful Improvement in Treatment Satisfaction with Teriflunomide Versus Subcutaneous IFNB-1A in Patients with Relapsing MS Results from Tenere.

M Mäurer1, B Van Wijmeersch2, J de Seze3, J Meca-Lallana4, S Bozzi5, P Vermersch6.   

Abstract

Entities:  

Year:  2014        PMID： 27200967     DOI： 10.1016/j.jval.2014.08.927

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  2 in total

1.  Treatment satisfaction in patients with relapsing-remitting multiple sclerosis initiated on teriflunomide in routine clinical practice: Australian observational data.

Authors:  Todd A Hardy; John Parratt; Heidi Beadnall; Stefan Blum; Richard Macdonell; Roy G Beran; Neil Shuey; Andrew Lee; William Carroll; Cameron Shaw; Richard Worrell; Jana Moody; Mamdouh Sedhom; Michael Barnett; Steve Vucic
Journal:  BMJ Neurol Open       Date:  2022-07-04

2.  Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?

Authors:  Patrick Vermersch; Jeremy Hobart; Catherine Dive-Pouletty; Sylvie Bozzi; Steven Hass; Patricia K Coyle
Journal:  Mult Scler       Date:  2016-07-11       Impact factor: 6.312
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.